Gross Profit On Sales تغییر دادن تاریخ
AbbVie USD 9.56B 95M 2023-09
Abbott USD 5.68B 147M 2023-12
Amgen USD 5.08B 14M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
Baxter International USD 1.49B 351M 2023-12
Bayer EUR 5.53B 796M 2023-09
Becton, Dickinson and Co. USD 2.03B 326M 2023-12
Biogen USD 1.77B 102.7M 2023-12
Boston Scientific USD 2.57B 135M 2023-12
Bristol-Myers Squibb USD 8.77B 294M 2023-12
CONMED USD 184.33M 16.27M 2023-12
Cooper Companies USD 606.5M 3.5M 2023-09
Dexcom USD 673.2M 49.9M 2023-12
Edwards Lifesciences USD 1.18B 46.7M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Globus Medical USD 351.05M 102.8M 2023-12
Hologic USD 567.5M 67.2M 2023-12
Insulet USD 361.2M 67.9M 2023-12
Integra LifeSciences USD 239.24M 14.93M 2023-12
Intuitive Surgical USD 1.28B 110.2M 2023-12
J&J USD 14.6B 374M 2023-12
Merck USD 11.29B 441M 2023-12
Merit Medical Systems USD 142.2M 10.58M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Stryker USD 3.71B 535M 2023-12
Tandem Diabetes Care USD 93.3M 3.54M 2023-12
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09
Zimmer Biomet Holdings USD 1.4B 166.3M 2023-12
Zoetis USD 1.49B 27M 2023-12



J&J سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.